Additional file 3 of Metabolic alteration in oxylipins and endocannabinoids point to an important role for soluble epoxide hydrolase and inflammation in Alzheimer’s disease—finding from Alzheimer’s Disease Neuroimaging Initiative

Kamil Borkowski; Chunyuan Yin; Alida S. D. Kindt; Nuanyi Liang; Elizabeth C. M. de Lange; Colette Blach; John W. Newman; Rima F Kaddurah-Daouk; Thomas Hankemeier

doi:10.6084/m9.figshare.31199273

Additional file 3 of Metabolic alteration in oxylipins and endocannabinoids point to an important role for soluble epoxide hydrolase and inflammation in Alzheimer’s disease—finding from Alzheimer’s Disease Neuroimaging Initiative

Figshare 2026 Open access

Read full text

Authors: Kamil Borkowski, Chunyuan Yin, Alida S. D. Kindt, Nuanyi Liang, Elizabeth C. M. de Lange, Colette Blach, John W. Newman, Rima F Kaddurah-Daouk, Thomas Hankemeier

DOI: 10.6084/m9.figshare.31199273

Cited by: 0

Fields of Study & Subjects

Alzheimer's disease research and treatments Dementia and Cognitive Impairment Research Eicosanoids and Hypertension Pharmacology

Publication details

Journal / source: Figshare
Publication date: 1 January 2026